SRPT Sarepta Therapeutics, Inc.

SRPT Sarepta Therapeutics, Inc.

Healthcare · Biotechnology

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $17.39 · VWAP $19.34 · -11.6% vs 12m avg buyer

downtrend vol: normalchurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

2 watchlists

Watchlists @biotech-scan@ibb

SRPT Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist SRPT belongs to, members best 30-day change first — SRPT highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

@ibb
@biotech-scan

Next earnings SRPT reports in 18 days Nov 4

Against street estimates

How SRPT's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 5 · projection Oct 16

Result
Aug 5 0.490.64 GAAP ≠ +31.7%Beat
May 6 1.053.16+202.1%Beat
Feb 25 -0.77-3.58-365.3%Miss
Nov 3 '25 -0.37-0.13 GAAP ≠ +65.0%Beat
Aug 6 '25 1.162.02+73.9%Beat
May 6 '25 -0.65-3.42-426.6%Miss
Feb 26 '25 2.061.90-7.8%Miss
Nov 6 '24 0.370.62 GAAP ≠ +67.0%Beat

Recent news

Headlines about SRPT from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 1 day ago · Oct 16

“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.

Types
Aug 5 Catalyst SRPT earnings
May 6 Catalyst SRPT earnings